Literature DB >> 10080567

Association between brain functional failure and dementia severity in Alzheimer's disease: resting versus stimulation PET study.

P Pietrini1, M L Furey, G E Alexander, M J Mentis, A Dani, M Guazzelli, S I Rapoport, M B Schapiro.   

Abstract

OBJECTIVE: This study tested the hypothesis that regional cerebral glucose metabolism during neuronal activation is a more sensitive index of neuronal dysfunction and clinical severity in Alzheimer's disease than is glucose metabolism at rest.
METHOD: The subjects were 15 Alzheimer's disease patients with a wide range of Mattis Dementia Rating Scale scores (23-128). By using positron emission tomography, absolute glucose metabolism was measured in the parietal, occipital (visual areas), and temporal (auditory areas) cortical regions during rest (eyes/ears covered) and audiovisual stimulation.
RESULTS: In the parietal cortex, glucose metabolism correlated with dementia severity in both conditions. In contrast, in the relatively preserved visual and auditory cortical regions, glucose metabolism predicted dementia severity during stimulation but not at rest.
CONCLUSIONS: These findings suggest that regional cerebral glucose metabolism during stimulation is a more sensitive index of the functional/metabolic failure of neuronal systems than is metabolism at rest.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10080567     DOI: 10.1176/ajp.156.3.470

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  10 in total

1.  The orbitofrontal cortex in methamphetamine addiction: involvement in fear.

Authors:  Rita Z Goldstein; Nora D Volkow; Linda Chang; Gene-Jack Wang; Joanna S Fowler; Richard A Depue; Ruben C Gur
Journal:  Neuroreport       Date:  2002-12-03       Impact factor: 1.837

2.  Quantitation, regional vulnerability, and kinetic modeling of brain glucose metabolism in mild Alzheimer's disease.

Authors:  Lisa Mosconi; Wai H Tsui; Henry Rusinek; Susan De Santi; Yi Li; Gene-Jack Wang; Alberto Pupi; Joanna Fowler; Mony J de Leon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-04-04       Impact factor: 9.236

3.  Global cerebral blood flow in relation to cognitive performance and reserve in subjects with mild memory deficits.

Authors:  Laura L Boles Ponto; Vincent A Magnotta; David J Moser; Kevin M Duff; Susan K Schultz
Journal:  Mol Imaging Biol       Date:  2006 Nov-Dec       Impact factor: 3.488

Review 4.  Organic psychosis: Insight into the biology of psychosis.

Authors:  N T Lautenschlager; H Förstl
Journal:  Curr Psychiatry Rep       Date:  2001-08       Impact factor: 5.285

Review 5.  Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.

Authors:  Lisa Mosconi; Alberto Pupi; Mony J De Leon
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 6.  A new integrative model of cerebral activation, deactivation and default mode function in Alzheimer's disease.

Authors:  Marc Wermke; Christian Sorg; Afra M Wohlschläger; Alexander Drzezga
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 9.236

7.  (13)C heteronuclear NMR studies of the interaction of cultured neurons and astrocytes and aluminum blockade of the preferential release of citrate from astrocytes.

Authors:  Shunsuke Meshitsuka; David A Aremu
Journal:  J Biol Inorg Chem       Date:  2007-11-15       Impact factor: 3.358

8.  Altered fMRI activation during mental rotation in those at genetic risk for Alzheimer disease.

Authors:  Michael A Yassa; Guillermo Verduzco; Catherine Cristinzio; Susan Spear Bassett
Journal:  Neurology       Date:  2008-05-13       Impact factor: 9.910

9.  Age-related alteration in cerebral blood flow and energy failure is correlated with cognitive impairment in the senescence-accelerated prone mouse strain 8 (SAMP8).

Authors:  Xuezhu Zhang; Guomin Li; Lin Guo; Kun Nie; Yujie Jia; Lan Zhao; Jianchun Yu
Journal:  Neurol Sci       Date:  2013-04-07       Impact factor: 3.307

10.  Impaired cross-modal inhibition in Alzheimer disease.

Authors:  Alexander Drzezga; Timo Grimmer; Martin Peller; Marc Wermke; Hartwig Siebner; Josef P Rauschecker; Markus Schwaiger; Alexander Kurz
Journal:  PLoS Med       Date:  2005-09-20       Impact factor: 11.069

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.